Details for Patent: 5,314,697
✉ Email this page to a colleague
Summary for Patent: 5,314,697
| Title: | Stable extended release oral dosage composition comprising loratadine and pseudoephedrine |
| Abstract: | A film-coated extended release oral dosage composition containing the nasal decongestant pseudoephedrine sulfate in a unique polymer matrix core and a film-coating on such core containing the non-sedating antihistamine, loratadine, and use of the said composition for treating patients showing the signs and symptoms associated with upper respiratory diseases and nasal congestion are disclosed. |
| Inventor(s): | Kwan; Henry K. (Summit, NJ), Liebowitz; Stephen M. (Neshanic Station, NJ) |
| Assignee: | Schering Corporation (Kenilworth, NJ) |
| Application Number: | 07/965,470 |
|
Patent Claim Types: see list of patent claims | Composition; Use; Dosage form; |
Drugs Protected by US Patent 5,314,697
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 5,314,697
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 161420 | ⤷ Sign Up | |||
| Australia | 5405094 | ⤷ Sign Up | |||
| Australia | 676229 | ⤷ Sign Up | |||
| Canada | 2147606 | ⤷ Sign Up | |||
| China | 1038474 | ⤷ Sign Up | |||
| China | 1089471 | ⤷ Sign Up | |||
| Czech Republic | 287687 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
